These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 3418827)

  • 1. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified?
    Quiñones-Baldrich WJ; Busuttil RW; Baker JD; Vescera CL; Ahn SS; Machleder HI; Moore WS
    J Vasc Surg; 1988 Sep; 8(3):219-28. PubMed ID: 3418827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Femoropopliteal bypass for claudication: vein vs. PTFE.
    Allen BT; Reilly JM; Rubin BG; Thompson RW; Anderson CB; Flye MW; Sicard GA
    Ann Vasc Surg; 1996 Mar; 10(2):178-85. PubMed ID: 8733871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions.
    Veith FJ; Gupta SK; Ascer E; White-Flores S; Samson RH; Scher LA; Towne JB; Bernhard VM; Bonier P; Flinn WR
    J Vasc Surg; 1986 Jan; 3(1):104-14. PubMed ID: 3510323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft type for femoro-popliteal bypass surgery.
    Ambler GK; Twine CP
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001487. PubMed ID: 29429146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: Polytetrafluoroethylene graft versus reversed saphenous vein.
    Ballotta E; Renon L; Toffano M; Da Giau G
    J Vasc Surg; 2003 Nov; 38(5):1051-5. PubMed ID: 14603216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Femoropopliteal bypass: saphenous vein and expanded polytetrafluoroethylene grafts.
    Wooster DL; Provan JL; Sojka SG; Madras PN
    Can J Surg; 1982 Nov; 25(6):666-9. PubMed ID: 7139424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study.
    Johnson WC; Lee KK
    J Vasc Surg; 2000 Aug; 32(2):268-77. PubMed ID: 10917986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?
    Sterpetti AV; Schultz RD; Feldhaus RJ; Peetz DJ
    J Vasc Surg; 1985 Nov; 2(6):907-12. PubMed ID: 3877178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of graft type on patency of infrainguinal arterial bypass grafts.
    Neale ML; Graham JC; Lane RJ; Cheung DS; Appleberg M
    J Am Coll Surg; 1994 Feb; 178(2):155-63. PubMed ID: 8173726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of stretch and non-stretch polytetrafluorethylene (PTFE) prosthetic grafts for femoro-popliteal bypass.
    Lu CH; Chang J; Lai ST; Shih CC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 May; 65(5):200-4. PubMed ID: 12166763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene.
    Archie JP
    Ann Vasc Surg; 1994 Sep; 8(5):475-84. PubMed ID: 7811585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polytetrafluoroethylene use for above-knee femoropopliteal bypass in critical limb ischemia.
    El-Kayali AA
    Saudi Med J; 2003 Jun; 24(6):669-71. PubMed ID: 12847601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value and limitations of secondary femoropopliteal bypasses with polytetrafluoroethylene.
    Yang PM; Wengerter KR; Veith FJ; Panetta TF; Nwosisi C; Gupta SK
    J Vasc Surg; 1991 Sep; 14(3):292-8. PubMed ID: 1880836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee.
    Woratyla SP; Darling RC; Chang BB; Paty PS; Kreienberg PB; Leather RP; Shah DM
    Am J Surg; 1997 Aug; 174(2):169-72. PubMed ID: 9293837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial.
    Devine C; McCollum C;
    J Vasc Surg; 2004 Nov; 40(5):924-31. PubMed ID: 15557906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts.
    Sala F; Hassen-Khodja R; Lecis A; Bouillanne PJ; Declemy S; Batt M
    Ann Vasc Surg; 2003 Jul; 17(4):401-7. PubMed ID: 14670018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts.
    Jackson MR; Belott TP; Dickason T; Kaiser WJ; Modrall JG; Valentine RJ; Clagett GP
    J Vasc Surg; 2000 Sep; 32(3):498-504; 504-5. PubMed ID: 10957656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Long-Term Outcomes of Femoropopliteal Bypass Surgery in Patients With Chronic Limb-Threatening Ischemia in an Endovascular Era.
    Betz T; Ingolf T; Markus S; Florian Z; Christian U
    Ann Vasc Surg; 2022 Feb; 79():191-200. PubMed ID: 34644653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Above-knee femoropopliteal reconstruction with polytetrafluoroethylene: a good alternative to saphenous vein bypass.
    Laurendeau F; Lassonde J
    Can J Surg; 1989 Jan; 32(1):48-50. PubMed ID: 2910380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.